4.6 Article

Intrapulmonary Delivery of CpG Microparticles Eliminates Lung Tumors

Journal

MOLECULAR CANCER THERAPEUTICS
Volume 14, Issue 10, Pages 2198-2205

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1535-7163.MCT-15-0401

Keywords

-

Categories

Funding

  1. NCI
  2. Ministry of Education, Culture, Sports, Science, and Technology of Japan [21790778, 23790917, 15K09224]
  3. Grants-in-Aid for Scientific Research [15K09224, 23790917, 21790778] Funding Source: KAKEN

Ask authors/readers for more resources

CpG oligonucleotides (ODN) stimulate the innate immune system by triggering cells that express TLR9. The resulting response promotes tumor regression, an effect optimized by delivery of CpG ODN to the tumor site. This work examines the effect of instilling CpG ODN adsorbed onto polyketal microparticles (CpG-MP) into the lungs of mice with non-small cell lung cancer. Intrapulmonary delivery of CpG-MP improved ODN uptake and retention at the tumor site, thereby inducing a stronger Th1 response than systemically administered or unadsorbed CpG ODN. CpG-MP reversed the immunosuppression that characterized the tumor microenvironment by (i) decreasing the number of immunosuppressive Tregs and M2 macrophages while (ii) increasing the number of tumoricidal CD8(+) T cells and M1 macrophages. These effects promoted tumor regression and culminated in 82% permanent survival of mice with otherwise fatal Lewis lung cancer. (C) 2015 AACR.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Construction of Genetically ModifiedLactococcus lactisProducing Anti-human-CTLA-4 Single-Chain Fragment Variable

Fu Namai, Aito Murakami, Asami Ueda, Masami Tsukagoshi, Suguru Shigemori, Tasuku Ogita, Takashi Sato, Takeshi Shimosato

MOLECULAR BIOTECHNOLOGY (2020)

Article Cell Biology

Identification of the Myogenetic Oligodeoxynucleotides (myoDNs) That Promote Differentiation of Skeletal Muscle Myoblasts by Targeting Nucleolin

Sayaka Shinji, Koji Umezawa, Yuma Nihashi, Shunichi Nakamura, Takeshi Shimosato, Tomohide Takaya

Summary: This study demonstrates that 18-base telomeric oligodeoxynucleotides designed from the Lactobacillus rhamnosus GG genome promote differentiation of skeletal muscle myoblasts by antagonizing nucleolin and modulating gene expression. The alkaloid berberine enhances the activity of the oligodeoxynucleotides by stabilizing and optimizing their conformation. These bacterial-derived oligodeoxynucleotides serve as aptamers and potential nucleic acid drugs that target myoblasts directly.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Physiology

Myogenetic Oligodeoxynucleotide (myoDN) Recovers the Differentiation of Skeletal Muscle Myoblasts Deteriorated by Diabetes Mellitus

Shunichi Nakamura, Shinichi Yonekura, Takeshi Shimosato, Tomohide Takaya

Summary: The study explores the use of novel myoDNs to promote the differentiation of myoblasts in diabetic patients, demonstrating that this approach effectively improves muscle wasting and has similar effects on healthy myoblasts exposed to high glucose or high lipid levels.

FRONTIERS IN PHYSIOLOGY (2021)

Article Immunology

Free Feeding of CpG-Oligodeoxynucleotide Particles Prophylactically Attenuates Allergic Airway Inflammation and Hyperresponsiveness in Mice

Takuma Okajima, Suguru Shigemori, Fu Namai, Tasuku Ogita, Takashi Sato, Takeshi Shimosato

Summary: The study found that prophylactic feeding of ODNcap can reduce allergic airway inflammation, hyperresponsiveness, and goblet cell hyperplasia in an ovalbumin-induced asthma model. Transcriptomics-driven approaches demonstrated that ODNcap feeding inhibits injury of pulmonary vein cardiomyocytes. Additionally, airway antimicrobial peptide and fecal microbiota participate in the ODNcap-mediated effects.

FRONTIERS IN IMMUNOLOGY (2021)

Article Virology

Longitudinal Analysis of Neutralizing Potency against SARS-CoV-2 in the Recovered Patients after Treatment with or without Favipiravir

Kanako Shinada, Takashi Sato, Saya Moriyama, Yu Adachi, Masahiro Shinoda, Shinichiro Ota, Miwa Morikawa, Masamichi Mineshita, Takayuki Matsumura, Yoshimasa Takahashi, Masaharu Shinkai

Summary: The use of favipiravir in the treatment of COVID-19 accelerates viral clearance, preserves the generation and persistence of neutralizing antibodies, and does not interfere with the maturation of neutralizing potency against both WT SARS-CoV-2 and its variants.

VIRUSES-BASEL (2022)

Article Chemistry, Multidisciplinary

Identification of a Novel Osteogenetic Oligodeoxynucleotide (osteoDN) That Promotes Osteoblast Differentiation in a TLR9-Independent Manner

Yuma Nihashi, Mana Miyoshi, Koji Umezawa, Takeshi Shimosato, Tomohide Takaya

Summary: The study identified an 18-base oligodeoxynucleotide (ODN) called iSN40 that enhances the activity and gene expression of osteoblasts, promoting their differentiation and calcium deposition. iSN40 may serve as a potential nucleic acid drug for osteoporosis therapy.

NANOMATERIALS (2022)

Article Biochemistry & Molecular Biology

Myogenetic Oligodeoxynucleotides as Anti-Nucleolin Aptamers Inhibit the Growth of Embryonal Rhabdomyosarcoma Cells

Naoki Nohira, Sayaka Shinji, Shunichi Nakamura, Yuma Nihashi, Takeshi Shimosato, Tomohide Takaya

Summary: In this study, it was found that embryonal rhabdomyosarcoma (ERMS) cells express nucleolin and their growth can be inhibited by anti-nucleolin aptamers. Further investigation revealed that iSN04 and AS1411, the two anti-nucleolin aptamers, not only suppress the proliferation of ERMS cells, but also promote their differentiation and myogenesis. Additionally, these anti-nucleolin aptamers disrupt the formation of tumor spheres in three-dimensional culture. Therefore, anti-nucleolin aptamers have the potential to be used as nucleic acid drugs for chemotherapy against ERMS.

BIOMEDICINES (2022)

Article Biotechnology & Applied Microbiology

Development of fluorescence-labeled antibody for immune checkpoint inhibitor using engineered probiotics

Fu Namai, Shunsuke Sumiya, Natsumi Nomura, Takashi Sato, Takeshi Shimosato

Summary: We developed genetically modified lactic acid bacteria (gmLAB) that produce green fluorescent protein (GFP)-conjugating, anti-programmed death-ligand 1 (PD-L1) single-chain variable fragments (scFv) for targeted cancer therapy. The gmLAB was able to express the anti-PD-L1 scFv and show specificity towards PD-L1 protein. These findings suggest that gmLAB could serve as an affordable diagnostic and treatment tool for cancer research.

AMB EXPRESS (2023)

Article Biochemistry & Molecular Biology

Development of a Single-Chain Fragment Variable that Binds to the SARS-CoV-2 Spike Protein Produced by Genetically Modified Lactic Acid Bacteria

Suzuka Oshima, Fu Namai, Takashi Sato, Takeshi Shimosato

Summary: In this study, a scFv based on the amino acid sequence of CC12.1 was designed to bind to the RBD of SARS-CoV-2 and enter cells through ACE2 receptors. Compared with the original antibody, scFv has the advantages of high tissue penetration and low production cost. gmLAB were constructed to incorporate the designed scFv and could be used as microbial therapeutics against COVID-19.

MOLECULAR BIOTECHNOLOGY (2023)

Article Multidisciplinary Sciences

Heterologous SARS-CoV-2 spike protein booster elicits durable and broad antibody responses against the receptor-binding domain

Tomohiro Takano, Takashi Sato, Ryutaro Kotaki, Saya Moriyama, Shuetsu Fukushi, Masahiro Shinoda, Kiyomi Kabasawa, Nagashige Shimada, Mio Kousaka, Yu Adachi, Taishi Onodera, Kazutaka Terahara, Masanori Isogawa, Takayuki Matsumura, Masaharu Shinkai, Yoshimasa Takahashi

Summary: Takano et al. demonstrate that a heterologous booster using a SARS-CoV-2 recombinant spike protein vaccine induces a more sustained and broader anti-spike receptor-binding domain antibody response compared to a homologous booster using an mRNA vaccine. The study shows that the S-268019-b spike protein booster generates higher and longer-lasting IgG titers specific to the SARS-CoV-2 spike receptor-binding domain, with the ability to bind to antigenically distinct variants, while the BNT162b2 mRNA homologous booster has a weaker effect. Additionally, the S-268019-b booster enhances the production of RBD-angiotensin-converting enzyme 2 (ACE2) binding inhibitory antibodies, resulting in increased neutralizing activities against Omicron BA.1 and BA.5 variants.

NATURE COMMUNICATIONS (2023)

Article Medicine, General & Internal

High Fever, Wide Distribution of Viral Pneumonia, and Pleural Effusion are More Critical Findings at the First Visit in Predicting the Prognosis of COVID-19: A Single Center, retrospective, Propensity Score-Matched Case-Control Study

Masahiro Shinoda, Shinichiro Ota, Yuto Yoshida, Takatomo Hirouchi, Kanako Shinada, Takashi Sato, Miwa Morikawa, Naoki Ishii, Masaharu Shinkai

Summary: High fever, widespread viral pneumonia, and pleural effusion may serve as easily measurable prognostic indicators in COVID-19 patients with similar backgrounds.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2023)

Article Agriculture, Dairy & Animal Science

Assessment of lactic acid bacteria isolated from the chicken digestive tract for potential use as poultry probiotics

Merisa Sirisopapong, Takeshi Shimosato, Supattra Okrathok, Sutisa Khempaka

Summary: This study aimed to characterize LAB strains from the chicken digestive tract and determine their potential as probiotics. The researchers found that the L. ingluviei and L. salivarius strains exhibited probiotic properties and improved the growth of broiler chickens. Future studies should investigate their potential for growth improvement in broilers.

ANIMAL BIOSCIENCE (2023)

Article Biochemistry & Molecular Biology

Myogenetic Oligodeoxynucleotide Induces Myocardial Differentiation of Murine Pluripotent Stem Cells

Mina Ishioka, Yuma Nihashi, Yoichi Sunagawa, Koji Umezawa, Takeshi Shimosato, Hiroshi Kagami, Tatsuya Morimoto, Tomohide Takaya

Summary: This study found that inhibition of nucleolin by iSN04 can promote the differentiation of cardiac mesoderm into cardiomyocytes but interferes with the differentiation of early mesoderm into the cardiac lineage. This is the first report on generating cardiomyocytes from pluripotent stem cells using a DNA aptamer. iSN04 does not induce hypertrophic responses in primary-cultured cardiomyocytes, making it useful and safe for regenerative therapy of heart failure using stem cell-derived cardiomyocytes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Agriculture, Dairy & Animal Science

Myogenetic oligodeoxynucleotide complexed with berberine promotes differentiation of chicken myoblasts

Yuma Nihashi, Sayaka Shinji, Koji Umezawa, Takeshi Shimosato, Tamao Ono, Hiroshi Kagami, Tomohide Takaya

Summary: Research has shown that certain myogenetic oligodeoxynucleotides (myoDNs) can promote the differentiation of chicken myoblasts into MHC-positive myotubes.

ANIMAL SCIENCE JOURNAL (2021)

Article Biochemistry & Molecular Biology

Nasally Administered Lactococcus lactis Secreting Heme Oxygenase-1 Attenuates Murine Emphysema

Kentaro Yumoto, Takashi Sato, Kentaro Nakashima, Fu Namai, Suguru Shigemori, Takeshi Shimosato, Takeshi Kaneko

ANTIOXIDANTS (2020)

No Data Available